Allogene Therapeutics Inc

Officers & Directors

Allogene Therapeutics Inc currently has 152 employees.

News about Allogene Therapeutics Inc Key Personnel

In Memoriam: A Legacy of Innovation Amidst Challenges – Allogene Therapeutics and the Visionary Leadership of David Bonderman

Allogene Therapeutics Faces a Pivotal Moment Following the Passing of Founding Board Member David Bonderman SOUTH SAN FRANCISCO, Calif. Dec. 12, 2024 — In the corridors of Allogene Therapeutics, Inc. the news of David Bonderman s passing reverberates deeply. A founding board member and influential figure in the biotechnology sector, Bonderman succumbed to age-related health issues at the age of 82, surrounded by his family. While his legacy as a visionary leader and financier is well-established, the future of Allogene Therapeutics now hangs in a delicate balance as the company grapples with financial struggles alongside significant potential in the biopharmaceutical landscape.Allogene Therapeutics, spec...

Business Description

Officers & Directors

ALLO Management Effectiveness

ALLO Revenue per Employee

ALLO Income per Employee

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.